New Payment Model for Cardiology Focused on Value-Based Care

Explore the new Ambulatory Specialty Model by CMS, focusing on value-based reimbursement for cardiologists in heart failure care. Learn its implications and requirements.

Medicare Drug Plans and Eli Lilly's $50 Cap Controversy

Eli Lilly's weight-loss drug plans face challenges with Medicare's $50 cap on out-of-pocket costs, impacting insurance regulations.

Understanding Medicare: A Guide for Retirement Planning

Explore the intricacies of Medicare, vital for retirement planning. Understand enrollment periods, benefits, and essential coverage options for optimal decision-making.

Investigation into New York's Medicaid Fraud and Healthcare Funding

Explore the investigation into New York's Medicaid fraud initiated by CMS, addressing funding issues and strengthening compliance against healthcare fraud.

Rising Prescription Drug Costs for Medicare Beneficiaries

Explore how rising prescription drug costs affect Medicare beneficiaries and learn about the Extra Help program for affordable medications.

Urgent Reforms Needed in Medicare's Graduate Medical Education Payments

Explore urgent reforms needed in Medicare's GME payments to address physician shortages and improve healthcare access in rural areas. A call to action for Congress.

Promoting Fairness for Medicare Providers Act: Impact on Insurance

Discover how the Promoting Fairness for Medicare Providers Act impacts reimbursement rates and insurance offerings for seniors, ensuring better healthcare access.

Fourth Quarter Earnings Reports: Health Insurance Sector Insights

Explore the Q4 earnings of health insurance companies like Cigna and Clover Health, highlighting market trends, challenges, and AI's role in the industry.

Texas Man Sentenced for Major Medicare Fraud Scheme

A Texas man was sentenced for a $60 million Medicare fraud scheme involving durable medical equipment, highlighting the enforcement of healthcare regulations.

Coverage Initiative for GLP-1 Medications in Medicare

CMS initiates a temporary coverage program for GLP-1 medications aiming to assist Medicare beneficiaries before full BALANCE Model implementation. Learn more.